Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (151-160 of 740) with videos related to

Pageof 74
Sort By:
AIDS Research and Human Retroviruses|October 1, 1995
The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNAS Kaye, E Comber, M Tenant-Flowers, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1Jason M Pogue, Brian A Potoski, Keith S Kaye
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2008
Development and testing of particulate formulations for the nasal delivery of antibodiesRichard S Kaye, Tarlochan S Purewal, Oya H Alpar
International Journal of Antimicrobial Agents|February 4, 2019
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experienceChristopher J Destache, David J Guervil, Keith S Kaye
Virulence|July 8, 2016
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant EnterobacteriaceaeJoshua T Thaden, Jason M Pogue, Keith S Kaye
International Journal of Antimicrobial Agents|November 24, 2016
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2016
Editorial Commentary: Colistin Dosing: Does the Fun Ever Start?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
JAMA|February 11, 2015
Contact precautions for patients with multidrug-resistant pathogens--replyDaniel J Morgan, Keith S Kaye, Daniel J Diekema
Infectious Disease Clinics of North America|December 15, 2019
Collaborative Antimicrobial Stewardship: Working with Hospital and Health System AdministrationWhitney R Buckel, Keith S Kaye, Payal K Patel
Journal of Personality Disorders|July 14, 1998
Factor structure of psychopathy among methadone maintenance patientsS Darke, S Kaye, R Finlay-Jones, et al.
Pageof 74

Showing results (151-160 of 740) with videos related to

Sort By:
Pageof 74
AIDS Research and Human Retroviruses|October 1, 1995
The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNAS Kaye, E Comber, M Tenant-Flowers, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1Jason M Pogue, Brian A Potoski, Keith S Kaye
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2008
Development and testing of particulate formulations for the nasal delivery of antibodiesRichard S Kaye, Tarlochan S Purewal, Oya H Alpar
International Journal of Antimicrobial Agents|February 4, 2019
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experienceChristopher J Destache, David J Guervil, Keith S Kaye
Virulence|July 8, 2016
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant EnterobacteriaceaeJoshua T Thaden, Jason M Pogue, Keith S Kaye
International Journal of Antimicrobial Agents|November 24, 2016
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2016
Editorial Commentary: Colistin Dosing: Does the Fun Ever Start?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
JAMA|February 11, 2015
Contact precautions for patients with multidrug-resistant pathogens--replyDaniel J Morgan, Keith S Kaye, Daniel J Diekema
Infectious Disease Clinics of North America|December 15, 2019
Collaborative Antimicrobial Stewardship: Working with Hospital and Health System AdministrationWhitney R Buckel, Keith S Kaye, Payal K Patel
Journal of Personality Disorders|July 14, 1998
Factor structure of psychopathy among methadone maintenance patientsS Darke, S Kaye, R Finlay-Jones, et al.
Pageof 74